International Biotechnology Trust’s Halozyme HALO Stock Holding History

International Biotechnology Trust’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.38M	Sell	62,200 -33,300	-35%	-$1.36M	0.8%	35
2023 Q2	$3.44M	Buy	95,500 +50,000	+110%	+$1.71M	1.05%	30
2023 Q1	$1.74M	Buy	+45,500	New	+$2.13M	0.48%	44
2021 Q3	–	Sell	-82,633	Closed	-$3.75M	–	72
2021 Q2	$3.75M	Buy	82,633 +48,000	+139%	+$2.12M	0.99%	26
2021 Q1	$1.44M	Sell	34,633 -273,000	-89%	-$12.5M	0.38%	41
2020 Q4	$13.1M	Hold	307,633	–	–	3.59%	13
2020 Q3	$8.07M	Hold	307,633	–	–	2.61%	15
2020 Q2	$7.94M	Hold	307,633	–	–	2.64%	16
2020 Q1	$5.53M	Hold	307,633	–	–	2.52%	16
2019 Q4	$5.45M	Buy	307,633 +255,000	+484%	+$4.42M	1.96%	18
2019 Q3	$816K	Sell	52,633 -423,000	-89%	-$6.97M	0.38%	45
2019 Q2	$8.16M	Hold	475,633	–	–	3.03%	13
2019 Q1	$7.66M	Buy	475,633 +77,000	+19%	+$1.25M	2.83%	12
2018 Q4	$4.58M	Sell	398,633 -30,000	-7%	-$479K	2.84%	13
2018 Q3	$5.97M	Hold	428,633	–	–	2.84%	12
2018 Q2	$7.23M	Buy	428,633 +70,000	+20%	+$1.32M	2.78%	15
2018 Q1	$7.03M	Buy	358,633 +76,000	+27%	+$1.47M	2.74%	14
2017 Q4	$5.72M	Hold	282,633	–	–	2.02%	19
2017 Q3	$4.91M	Buy	282,633 +78,000	+38%	+$1.06M	1.91%	17
2017 Q2	$2.62M	Sell	204,633 -153,367	-43%	-$2.05M	1%	32
2017 Q1	$4.64M	Buy	358,000 +300,000	+517%	+$3.79M	1.77%	16
2016 Q4	$572K	Buy	+58,000	New	+$635K	0.26%	44

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

International Biotechnology Trust's HALO Position: Q3 2023 in Review

International Biotechnology Trust reduced its Halozyme (HALO) stake by 35% in Q3 2023, selling an estimated $1.36M and leaving 62,200 shares worth $2.38M. The position accounts for 0.8% of the portfolio, ranked #35.

International Biotechnology Trust first reported a position in HALO in Q4 2016 and has held it in 22 quarters since. The position peaked at $13.1M in Q4 2020. 389 funds tracked by Wall St. Rank hold HALO as of Q3 2023.

International Biotechnology Trust held 62,200 shares of Halozyme worth $2.38M as of Q3 2023.
International Biotechnology Trust sold 33,300 Halozyme shares in Q3 2023, an estimated $1.36M.
Halozyme made up 0.8% of International Biotechnology Trust's portfolio in Q3 2023, its #35 holding.
International Biotechnology Trust first reported a position in Halozyme in Q4 2016 and has held it in 22 quarters since.
International Biotechnology Trust's Halozyme position peaked at $13.1M in Q4 2020.
389 funds tracked by Wall St. Rank held Halozyme as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.